Avalanche (AVAX) is back in the spotlight after reclaiming its position among the top 20 cryptos to surpass Hedera (HBAR), just as Securitize secures EU approval to launch the region\u2019s first fully regulated blockchain-based securities market on the Avalanche network.<\/p>\n
This convergence of regulatory momentum, institutional adoption, and renewed technical strength has positioned AVAX for a potential market revival heading into 2026.<\/p>\n\n
Securitize received regulatory authorization from Spain\u2019s National Securities Market Commission (CNMV) to operate a tokenized trading and settlement system under the EU\u2019s DLT Pilot Regime.<\/p>\n
The approval enables Securitize to passport the license across the European Single Market, including France, Germany, and Italy, creating an unprecedented bridge between its U.S. broker-dealer operations and Europe\u2019s capital markets.<\/p>\n
The firm confirmed that the entire infrastructure will run on the Avalanche blockchain, citing sub-second finality, regulatory-grade network performance, and scalable architecture.<\/p>\n
This move positions Avalanche at the center of institutional tokenization just as Securitize prepares for a $1.25 billion SPAC merger and expands its portfolio, including managing the now-over $1 billion BlackRock BUIDL<\/a> on-chain treasury fund.<\/p>\n The first EU-compliant issuance is slated for early 2026, opening the door for a wave of regulated tokenized assets, an estimated $18 trillion market by 2033.<\/p>\n While fundamentals surge, AVAX\u2019s price remains compressed near the long-term support zone around $12\u2013$15. The token recently bounced to $14.94, posting a 6.5% daily gain and breaking above its 7-day moving average at $13.96. It now faces a technical showdown with resistance at the 20-day SMA at $15.21.<\/p>\n Momentum indicators are turning constructive. RSI sits at a healthy 42, MACD shows bullish divergence, and Stochastic momentum favors buyers. A breakout above $15.21 could open the path toward $18.61, with a larger target near $33 if long-term trendlines snap.<\/p>\n However, failure to hold above $13.91 risks retesting deeper support near $12.57.<\/p>\nAVAX Price Holds Key Support as Technical Signals Improve<\/strong><\/h2>\n